NeuroDex gets research grant from The Michael J. Fox Foundation to develop blood-based biomarker for Parkinson’s disease: Natick, Massachusetts Friday, November 15, 2024, 17:00 ...

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

In her latest column, Gretchen Reynolds writes about a large new study of more than 83,000 adults that found that standing ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

Kenai Therapeutics today announced the formation of a Patient Advisory Board comprised of leading experts and advocates in ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...

When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

On the Hoenya scale, which divided Parkinson's disease symptoms into stages 1 to 5 by increasing them according to their ...